Last 12 months
Inside the activity.
0 purchase rows · 75 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 11 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 6 |
| Feb 2026 | 0 | 8 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 7 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 26, 2021 Filed Jan 29, 2021 00:45 UTC |
Dickinson Andrew DEVP, Chief Financial Officer
|
GrantCommon Stock | 12,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002910 · form4.xml · nonDerivative · entry 1 Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,200 F1 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 6, 2019, and March 10, 2020. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met. Read SEC document |
| January 26, 2021 Filed Jan 29, 2021 00:52 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
GrantCommon Stock | 59,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002912 · form4.xml · nonDerivative · entry 1 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,670 F1 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 1, 2019, and March 10, 2020. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met. Read SEC document |
| January 26, 2021 Filed Jan 29, 2021 00:57 UTC |
Parsey MerdadChief Medical Officer
|
GrantCommon Stock | 9,214 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002914 · form4.xml · nonDerivative · entry 1 Parsey Merdad · CIK 0001792150 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,899 F1 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2020. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met. Read SEC document |
| January 26, 2021 Filed Jan 29, 2021 01:04 UTC |
Mercier JohannaChief Commercial Officer
|
GrantCommon Stock | 8,068 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002916 · form4.xml · nonDerivative · entry 1 Mercier Johanna · CIK 0001782135 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,974 F1 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2020. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met. Read SEC document |
| January 26, 2021 Filed Jan 29, 2021 01:06 UTC |
Wilfong Diane E.SVP, Controller & CAO
|
GrantCommon Stock | 1,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002918 · form4.xml · nonDerivative · entry 1 Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,495 F1 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 6, 2019, and March 10, 2020. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met. Read SEC document |
| January 26, 2021 Filed Jan 29, 2021 01:08 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
Tax withholdingCommon Stock | 3,736 | $66.70 | $249,191.20 |
DisclosureSEC source: 0001127602-21-002920 · form4.xml · nonDerivative · entry 3 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,543 Read SEC document |
| January 26, 2021 Filed Jan 29, 2021 01:08 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
GrantCommon Stock | 13,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002920 · form4.xml · nonDerivative · entry 2 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,279 F2 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2018. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. Read SEC document |
| January 26, 2021 Filed Jan 29, 2021 01:08 UTC |
Pletcher Brett AEVP,Corp Affairs & Gen Counsel
|
GrantCommon Stock | 14,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002920 · form4.xml · nonDerivative · entry 1 Pletcher Brett A · CIK 0001739307 · EVP,Corp Affairs & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,832 F1 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 6, 2019, and March 10, 2020. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met. Read SEC document |
| January 22, 2021 Filed Jan 25, 2021 18:55 UTC |
Lofton Kevin EDirector
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 20,282 | $0.00 Strike: $20.65 | $0.00 |
DisclosureSEC source: 0001127602-21-002420 · form4.xml · derivative · entry 2 Lofton Kevin E · CIK 0001468818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,282 shares Expires 2021-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested quarterly over one year and were fully vested on May 12, 2012. Read SEC document |
| January 22, 2021 Filed Jan 25, 2021 18:55 UTC |
Lofton Kevin EDirector
|
Exercise / conversionCommon Stock | 20,282 | $20.65 | $418,721.89 |
DisclosureSEC source: 0001127602-21-002420 · form4.xml · nonDerivative · entry 1 Lofton Kevin E · CIK 0001468818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2020 Filed Jan 4, 2021 18:21 UTC |
Lofton Kevin EDirector
|
GrantPhantom Stock · Derivative | 33.8286 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000082 · form4.xml · derivative · entry 1 Lofton Kevin E · CIK 0001468818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,852.0483 Underlying: Common Stock · 33.8286 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| December 30, 2020 Filed Jan 4, 2021 18:24 UTC |
Whitley Richard JamesDirector
|
GrantPhantom Stock · Derivative | 68.8983 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000084 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,808.7328 Underlying: Common Stock · 68.8983 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 21:10 UTC |
Bluestone JeffreyDirector
|
GrantRestricted Stock Unit · Derivative | 1,041 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-031071 · form4.xml · derivative · entry 2 Bluestone Jeffrey · CIK 0001771814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,041 Underlying: Common Stock · 1,041 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units vest on December 8, 2021. F3 · derivative.expiration_date: 100% of the restricted stock units vest on December 8, 2021. Read SEC document |
| December 08, 2020 Filed Dec 10, 2020 21:10 UTC |
Bluestone JeffreyDirector
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 5,879 | $0.00 Strike: $61.17 | $0.00 |
DisclosureSEC source: 0001127602-20-031071 · form4.xml · derivative · entry 1 Bluestone Jeffrey · CIK 0001771814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,879 Underlying: Common Stock · 5,879 shares Expires 2030-12-08 F1 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary measured from December 8, 2020 such that 100% of the shares subject to the option will be fully vested and exercisable on December 8, 2021. Read SEC document |
| November 23, 2020 Filed Dec 29, 2020 20:06 UTC |
Lofton Kevin EDirector
|
GiftCommon Stock | 21,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-032439 · form4.xml · nonDerivative · entry 1 Lofton Kevin E · CIK 0001468818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,921 F1 · kind: Reflects the gift of common stock to a charitable donor advised fund. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:34 UTC |
Wilfong Diane E.SVP, Controller & CAO
|
Exercise / conversionRestricted Stock Unit · Derivative | 657 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-028854 · form4.xml · derivative · entry 5 Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,971 Underlying: Common Stock · 657 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. F3 · derivative.expiration_date: The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:34 UTC |
Wilfong Diane E.SVP, Controller & CAO
|
Exercise / conversionRestricted Stock Unit · Derivative | 773 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-028854 · form4.xml · derivative · entry 4 Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,628 Underlying: Common Stock · 773 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested. F2 · derivative.expiration_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:34 UTC |
Wilfong Diane E.SVP, Controller & CAO
|
Tax withholdingCommon Stock | 611 | $60.62 | $37,038.82 |
DisclosureSEC source: 0001127602-20-028854 · form4.xml · nonDerivative · entry 3 Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,201 Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:34 UTC |
Wilfong Diane E.SVP, Controller & CAO
|
Exercise / conversionCommon Stock | 657 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-028854 · form4.xml · nonDerivative · entry 2 Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:34 UTC |
Wilfong Diane E.SVP, Controller & CAO
|
Exercise / conversionCommon Stock | 773 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-028854 · form4.xml · nonDerivative · entry 1 Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:44 UTC |
Parsey MerdadChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,101 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-028865 · form4.xml · derivative · entry 3 Parsey Merdad · CIK 0001792150 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,019 Underlying: Common Stock · 5,101 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on the anniversary of the date of grant until fully vested. F2 · derivative.expiration_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on the anniversary of the date of grant until fully vested. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:44 UTC |
Parsey MerdadChief Medical Officer
|
Tax withholdingCommon Stock | 2,416 | $60.62 | $146,457.92 |
DisclosureSEC source: 0001127602-20-028865 · form4.xml · nonDerivative · entry 2 Parsey Merdad · CIK 0001792150 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,685 Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:44 UTC |
Parsey MerdadChief Medical Officer
|
Exercise / conversionCommon Stock | 5,101 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-028865 · form4.xml · nonDerivative · entry 1 Parsey Merdad · CIK 0001792150 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:50 UTC |
Dickinson Andrew DEVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,913 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-028870 · form4.xml · derivative · entry 5 Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,118 Underlying: Common Stock · 1,913 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested. F3 · derivative.expiration_date: The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:50 UTC |
Dickinson Andrew DEVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,133 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-028870 · form4.xml · derivative · entry 4 Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,031 Underlying: Common Stock · 1,133 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested. F2 · derivative.expiration_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:50 UTC |
Dickinson Andrew DEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 1,399 | $60.62 | $84,807.38 |
DisclosureSEC source: 0001127602-20-028870 · form4.xml · nonDerivative · entry 3 Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,286 Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:50 UTC |
Dickinson Andrew DEVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 1,913 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-028870 · form4.xml · nonDerivative · entry 2 Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,685 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 22:50 UTC |
Dickinson Andrew DEVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 1,133 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-028870 · form4.xml · nonDerivative · entry 1 Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 22:16 UTC |
Mercier JohannaChief Commercial Officer
|
Tax withholdingCommon Stock | 12,282 | $58.83 | $722,550.06 |
DisclosureSEC source: 0001127602-20-028266 · form4.xml · nonDerivative · entry 2 Mercier Johanna · CIK 0001782135 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,906 Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 22:16 UTC |
Mercier JohannaChief Commercial Officer
|
GrantCommon Stock | 26,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-028266 · form4.xml · nonDerivative · entry 1 Mercier Johanna · CIK 0001782135 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,188 F1 · shares: Issuance of common stock upon vesting of certain performance share awards on November 3, 2020. Read SEC document |
| October 22, 2020 Filed Oct 26, 2020 23:12 UTC |
WELTERS ANTHONYDirector
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 7,718 | $0.00 Strike: $60.67 | $0.00 |
DisclosureSEC source: 0001127602-20-027542 · form4.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,718 Underlying: Common Stock · 7,718 shares Expires 2030-10-22 F3 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary measured from October 22, 2020 such that 100% of the shares subject to the option will be fully vested and exercisable on October 22, 2021. Read SEC document |
| October 22, 2020 Filed Oct 26, 2020 23:12 UTC |
WELTERS ANTHONYDirector
|
GrantRestricted Stock Unit · Derivative | 1,368 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-027542 · form4.xml · derivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 Underlying: Common Stock · 1,368 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units will vest on October 22, 2021. F2 · derivative.expiration_date: 100% of the restricted stock units will vest on October 22, 2021. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 23:09 UTC |
Whitley Richard JamesDirector
|
Exercise / conversionPhantom Stock · Derivative | 1,434 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026596 · form4.xml · derivative · entry 2 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,739.8344 Underlying: Common Stock · 1,434 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: An aggregate of 1434.958608 shares were reported in Table II when the reporting person acquired the phantom shares. The fractional share of 0.958608 was paid out in cash in connection with the conversion into shares of common stock. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 23:09 UTC |
Whitley Richard JamesDirector
|
Exercise / conversionCommon Stock | 1,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026596 · form4.xml · nonDerivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. Read SEC document |
| September 29, 2020 Filed Oct 1, 2020 21:07 UTC |
Lofton Kevin EDirector
|
GrantPhantom Stock · Derivative | 30.5255 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026041 · form4.xml · derivative · entry 1 Lofton Kevin E · CIK 0001468818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,818.2197 Underlying: Common Stock · 30.5255 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| September 29, 2020 Filed Oct 1, 2020 21:20 UTC |
Whitley Richard JamesDirector
|
GrantPhantom Stock · Derivative | 77.7136 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026051 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,174.793 Underlying: Common Stock · 77.7136 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 16:53 UTC |
Parsey MerdadChief Medical Officer
|
SaleCommon Stock | 182 | $68.32 | $12,434.24 |
DisclosureSEC source: 0001127602-20-023865 · form4.xml · nonDerivative · entry 2 Parsey Merdad · CIK 0001792150 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · kind: The sale transaction reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 15, 2020 Filed Aug 19, 2020 16:53 UTC |
Parsey MerdadChief Medical Officer
|
GrantCommon Stock | 182 | $57.43 | $10,451.53 |
DisclosureSEC source: 0001127602-20-023865 · form4.xml · nonDerivative · entry 1 Parsey Merdad · CIK 0001792150 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Gilead Sciences, Inc. Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of February 16, 2020 through August 15, 2020. This transaction is exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's stock on February 16, 2020. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 18:59 UTC |
Wilfong Diane E.SVP, Controller & CAO
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,345 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-023432 · form4.xml · derivative · entry 3 Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,401 Underlying: Common Stock · 3,345 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested. F2 · derivative.expiration_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 18:59 UTC |
Wilfong Diane E.SVP, Controller & CAO
|
Tax withholdingCommon Stock | 1,384 | $68.51 | $94,817.84 |
DisclosureSEC source: 0001127602-20-023432 · form4.xml · nonDerivative · entry 2 Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,382 Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 18:59 UTC |
Wilfong Diane E.SVP, Controller & CAO
|
Exercise / conversionCommon Stock | 3,345 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-023432 · form4.xml · nonDerivative · entry 1 Wilfong Diane E. · CIK 0001374988 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:57 UTC |
Dickinson Andrew DEVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,306 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-023463 · form4.xml · derivative · entry 3 Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,164 Underlying: Common Stock · 2,306 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested. F2 · derivative.expiration_date: The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:57 UTC |
Dickinson Andrew DEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 1,022 | $68.51 | $70,017.22 |
DisclosureSEC source: 0001127602-20-023463 · form4.xml · nonDerivative · entry 2 Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,639 Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:57 UTC |
Dickinson Andrew DEVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 2,306 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-023463 · form4.xml · nonDerivative · entry 1 Dickinson Andrew D · CIK 0001310204 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:47 UTC |
Mercier JohannaChief Commercial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-022184 · form4.xml · derivative · entry 3 Mercier Johanna · CIK 0001782135 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,615 Underlying: Common Stock · 7,505 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units have a four- year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. F2 · derivative.expiration_date: The restricted stock units have a four- year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:47 UTC |
Mercier JohannaChief Commercial Officer
|
Tax withholdingCommon Stock | 3,587 | $73.64 | $264,146.68 |
DisclosureSEC source: 0001127602-20-022184 · form4.xml · nonDerivative · entry 2 Mercier Johanna · CIK 0001782135 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,918 Read SEC document |
| July 24, 2020 Filed Jul 28, 2020 22:47 UTC |
Mercier JohannaChief Commercial Officer
|
Exercise / conversionCommon Stock | 7,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-022184 · form4.xml · nonDerivative · entry 1 Mercier Johanna · CIK 0001782135 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 29, 2020 Filed Jul 1, 2020 20:55 UTC |
Lofton Kevin EDirector
|
GrantPhantom Stock · Derivative | 25.1945 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-020665 · form4.xml · derivative · entry 1 Lofton Kevin E · CIK 0001468818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,787.6942 Underlying: Common Stock · 25.1945 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| June 29, 2020 Filed Jul 1, 2020 21:03 UTC |
Whitley Richard JamesDirector
|
GrantPhantom Stock · Derivative | 64.1416 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-020666 · form4.xml · derivative · entry 1 Whitley Richard James · CIK 0001441661 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,097.0794 Underlying: Common Stock · 64.1416 shares Expires not disclosed F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock. F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate. F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 17:51 UTC |
Rodriguez JavierDirector
|
SaleCommon Stock | 189 | $75.50 | $14,269.50 |
DisclosureSEC source: 0001127602-20-020353 · form4.xml · nonDerivative · entry 1 Rodriguez Javier · CIK 0001415548 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.